Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer.
D000380:Agranulocytosis; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D013293:Enterococcus faecalis / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007709:Klebsiella / Q000302:isolation & purification; D007938:Leukemia / Q000150:complications*; D008223:Lymphoma / Q000150:complications; D011113:Polymyxins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D013210:Staphylococcus / Q000302:isolation & purification
D005839:Gentamicins; D011113:Polymyxins; D002228:Carbenicillin; D002512:Cephalothin